Login
Home
Charts
Search
Watchlist
Products

Divis Laboratories Ltd

DIVISLAB·NSE
₹9,331.50-0.84%Tue, 22 Sept '26 13:52
Industry:Pharma - API & CRAMS
Indices:

Divis Laboratories Ltd

DIVISLAB
NSE
₹9,331.50
-0.84%
|Tue, 22 Sept '26 13:52
SOICxStockScans Reports
Industry
Pharma - API & CRAMS
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,47,589Cr
Close
Close Price
₹9,326.50
Industry
Industry
Pharma - API & CRAMS
PE
Price To Earnings
84.62
PS
Price To Sales
22.05
Revenue
Revenue
₹11,230Cr
Rev Gr TTM
Revenue Growth TTM
16.35%
PAT Gr TTM
PAT Growth TTM
26.84%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,9091,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,080
Growth YoY
Revenue Growth YoY%
2.98.618.019.122.525.012.213.816.112.39.527.8
Expenses
ExpensesCr
1,4301,3661,5721,4961,6221,5761,6991,6811,8271,7141,8971,825
Operating Profit
Operating ProfitCr
4794897316227167438867298888909341,255
OPM
OPM%
25.126.431.729.430.632.034.330.332.734.233.040.8
Other Income
Other IncomeCr
8695797910682861191451415564
Interest Expense
Interest ExpenseCr
102010138666
Depreciation
DepreciationCr
959595979999107112113118120133
PBT
PBTCr
4694897136047227268647339127809631,180
Tax
TaxCr
121131175174212137202188223197212278
PAT
PATCr
348358538430510589662545689583751902
Growth YoY
PAT Growth YoY%
-29.417.067.620.846.564.523.126.735.1-1.013.465.5
NPM
NPM%
18.219.323.420.321.825.425.622.625.422.426.529.3
EPS
EPS₹
13.113.520.316.219.222.224.920.526.022.028.334.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,9091,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,080
Growth YoY
Revenue Growth YoY%
2.98.618.019.122.525.012.213.816.112.39.527.8
Expenses
ExpensesCr
1,4301,3661,5721,4961,6221,5761,6991,6811,8271,7141,8971,825
Operating Profit
Operating ProfitCr
4794897316227167438867298888909341,255
OPM
OPM%
25.126.431.729.430.632.034.330.332.734.233.040.8
Other Income
Other IncomeCr
8695797910682861191451415564
Interest Expense
Interest ExpenseCr
102010138666
Depreciation
DepreciationCr
959595979999107112113118120133
PBT
PBTCr
4694897136047227268647339127809631,180
Tax
TaxCr
121131175174212137202188223197212278
PAT
PATCr
348358538430510589662545689583751902
Growth YoY
PAT Growth YoY%
-29.417.067.620.846.564.523.126.735.1-1.013.465.5
NPM
NPM%
18.219.323.420.321.825.425.622.625.422.426.529.3
EPS
EPS₹
13.113.520.316.219.222.224.920.526.022.028.334.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7764,0643,8914,9465,3946,9698,9607,7687,8459,36010,56011,230
Growth
Revenue Growth%
21.27.6-4.327.19.129.228.6-13.31.019.312.816.4
Expenses
ExpensesCr
2,3592,6182,6303,0743,5724,1095,0785,4005,6406,3927,1197,263
Operating Profit
Operating ProfitCr
1,4171,4461,2621,8721,8222,8603,8822,3682,2052,9683,4413,967
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.635.3
Other Income
Other IncomeCr
977511315619063114345339352433378
Interest Expense
Interest ExpenseCr
42146111322326
Depreciation
DepreciationCr
118123142169186256312343378402463484
PBT
PBTCr
1,3931,3951,2311,8551,8192,6663,6842,3692,1632,9163,3883,835
Tax
TaxCr
267335354502443682723545563725820910
PAT
PATCr
1,1261,0608771,3531,3771,9842,9601,8231,6002,1912,5682,925
Growth
PAT Growth%
32.2-5.8-17.354.21.844.149.2-38.4-12.336.917.226.8
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.326.1
EPS
EPS₹
42.440.033.051.051.974.8111.568.760.382.596.8110.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7764,0643,8914,9465,3946,9698,9607,7687,8459,36010,56011,230
Growth
Revenue Growth%
21.27.6-4.327.19.129.228.6-13.31.019.312.816.4
Expenses
ExpensesCr
2,3592,6182,6303,0743,5724,1095,0785,4005,6406,3927,1197,263
Operating Profit
Operating ProfitCr
1,4171,4461,2621,8721,8222,8603,8822,3682,2052,9683,4413,967
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.635.3
Other Income
Other IncomeCr
977511315619063114345339352433378
Interest Expense
Interest ExpenseCr
42146111322326
Depreciation
DepreciationCr
118123142169186256312343378402463484
PBT
PBTCr
1,3931,3951,2311,8551,8192,6663,6842,3692,1632,9163,3883,835
Tax
TaxCr
267335354502443682723545563725820910
PAT
PATCr
1,1261,0608771,3531,3771,9842,9601,8231,6002,1912,5682,925
Growth
PAT Growth%
32.2-5.8-17.354.21.844.149.2-38.4-12.336.917.226.8
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.326.1
EPS
EPS₹
42.440.033.051.051.974.8111.568.760.382.596.8110.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
5353535353535353535353
Reserves
ReservesCr
4,2405,3045,8726,9047,2579,24211,67512,71413,51814,91616,708
Current Liabilities
Current LiabilitiesCr
5206596538479271,1121,1961,1011,2781,4522,043
Non Current Liabilities
Non Current LiabilitiesCr
891422082342993674515716215111,229
Total Liabilities
Total LiabilitiesCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,033
Current Assets
Current AssetsCr
3,0274,0114,5354,6504,6806,1758,3529,3129,67510,08111,096
Non Current Assets
Non Current AssetsCr
1,8752,1482,2513,3883,8564,5995,0235,1275,7956,8518,937
Total Assets
Total AssetsCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,033
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
5353535353535353535353
Reserves
ReservesCr
4,2405,3045,8726,9047,2579,24211,67512,71413,51814,91616,708
Current Liabilities
Current LiabilitiesCr
5206596538479271,1121,1961,1011,2781,4522,043
Non Current Liabilities
Non Current LiabilitiesCr
891422082342993674515716215111,229
Total Liabilities
Total LiabilitiesCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,033
Current Assets
Current AssetsCr
3,0274,0114,5354,6504,6806,1758,3529,3129,67510,08111,096
Non Current Assets
Non Current AssetsCr
1,8752,1482,2513,3883,8564,5995,0235,1275,7956,8518,937
Total Assets
Total AssetsCr
4,9026,1596,7868,0388,53610,77413,37514,43915,47016,93220,033

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0381,1507769541,2161,9471,9122,4601,2611,6532,738
Investing Cash Flow
Investing Cash FlowCr
-406-1,140-478-685-8375-2,195-2,708-269-804-2,219
Financing Cash Flow
Financing Cash FlowCr
-6312-314-246-1,091-35-532-797-799-799-804
Net Cash Flow
Net Cash FlowCr
013-1723411,987-816-1,04519350-285
Free Cash Flow
Free Cash FlowCr
642774502221331,0371,1991,987258215221
CFO To PAT
CFO To PAT%
92.2108.588.570.588.398.164.6134.978.875.5106.6
CFO To EBITDA
CFO To EBITDA%
73.279.561.551.066.768.149.3103.957.255.779.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0381,1507769541,2161,9471,9122,4601,2611,6532,738
Investing Cash Flow
Investing Cash FlowCr
-406-1,140-478-685-8375-2,195-2,708-269-804-2,219
Financing Cash Flow
Financing Cash FlowCr
-6312-314-246-1,091-35-532-797-799-799-804
Net Cash Flow
Net Cash FlowCr
013-1723411,987-816-1,04519350-285
Free Cash Flow
Free Cash FlowCr
642774502221331,0371,1991,987258215221
CFO To PAT
CFO To PAT%
92.2108.588.570.588.398.164.6134.978.875.5106.6
CFO To EBITDA
CFO To EBITDA%
73.279.561.551.066.768.149.3103.957.255.779.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
26,15016,56928,92345,21552,76396,3661,16,90875,01591,2351,53,2581,57,8622,47,589
Price To Earnings
Price To Earnings
23.215.633.033.438.348.639.541.156.969.861.484.6
Price To Sales
Price To Sales
6.94.17.49.19.813.813.19.711.616.414.922.1
Price To Book
Price To Book
6.13.14.96.57.210.410.05.96.710.29.414.8
EV To EBITDA
EV To EBITDA
18.411.422.924.128.932.929.429.939.650.444.961.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.053.650.354.051.458.258.749.648.351.152.152.1
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.635.3
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.326.1
ROCE
ROCE%
32.225.920.626.324.828.731.418.616.019.520.320.3
ROE
ROE%
26.219.814.819.418.821.425.214.311.814.615.315.3
ROA
ROA%
23.017.212.916.816.118.422.112.610.312.912.812.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
26,15016,56928,92345,21552,76396,3661,16,90875,01591,2351,53,2581,57,8622,47,589
Price To Earnings
Price To Earnings
23.215.633.033.438.348.639.541.156.969.861.484.6
Price To Sales
Price To Sales
6.94.17.49.19.813.813.19.711.616.414.922.1
Price To Book
Price To Book
6.13.14.96.57.210.410.05.96.710.29.414.8
EV To EBITDA
EV To EBITDA
18.411.422.924.128.932.929.429.939.650.444.961.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
52.053.650.354.051.458.258.749.648.351.152.152.1
OPM
OPM%
37.535.632.437.833.841.043.330.528.131.732.635.3
NPM
NPM%
29.826.122.527.425.528.533.023.520.423.424.326.1
ROCE
ROCE%
32.225.920.626.324.828.731.418.616.019.520.320.3
ROE
ROE%
26.219.814.819.418.821.425.214.311.814.615.315.3
ROA
ROA%
23.017.212.916.816.118.422.112.610.312.912.812.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Divis Laboratories Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/tgw5dru88ta4eikm2zwugwxo.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/1hsow63wdhy8f5cqwsai1dgc.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/tn4gum3g72kxibq9nt7hbyaa.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/so2lhwwl8l3cuu8nzvmnw0v6.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/z86oqbi4entg62wc8fcl40ib.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/y6w9232bz8rw8oaghsc1x2gn.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/xs1mwbei6d5ugaum53fx352q.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/tnwacisvdy5g1jw19b114cro.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ushsr1uxqc7oxwcsp9yhkmgq.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/s7cm7mhzm49gy1tudezuhay3.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/mvxjygt7klgrr4fudfpxq1sr.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/o4p61ystgg43dkafkxdl22zp.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/t9mevy13pmcg729frhzy3wrc.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/js7vc9txzjm2xcuwksib052a.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/z3tfar4s789dlunqty0o21z1.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/f94kse8cho9y1k066ifhwe1m.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/9q4bjxlqjc0vcrp3zzaqjmdp.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/8ctsc2jl5dtr00pgfwb24m06.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/jrorr0qe0mrecy6v6k01zfeo.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/dczquyxw724fjmxx5xuddsxe.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/73fcfbwfk0om9chm9ix1ntea.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/gq55ow7a7oc8xbgfpygj0ijc.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/8wa7du1dgdtzas71r4bkw4py.pdf

Concall Transcript Summaries — Divis Laboratories Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202606/tgw5dru88ta4eikm2zwugwxo.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202603/1hsow63wdhy8f5cqwsai1dgc.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202512/tn4gum3g72kxibq9nt7hbyaa.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202509/so2lhwwl8l3cuu8nzvmnw0v6.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202506/z86oqbi4entg62wc8fcl40ib.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202503/y6w9232bz8rw8oaghsc1x2gn.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202412/xs1mwbei6d5ugaum53fx352q.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ADIVISLAB/transcript-notes/202409/tnwacisvdy5g1jw19b114cro.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies